Article Text
PDF
Statistics from Altmetric.com
G H Bardy
Dr G H Bardy, Seattle Institute for Cardiac Research, Seattle, WA, USA; gbardy@sicr.org
QUESTION
In stable patients at increased risk of sudden cardiac arrest, does having an automated external defibrillator (AED) in the home reduce all-cause mortality compared with training in usual emergency procedures?
METHODS
Design:
randomised controlled trial (Home Automated External Defibrillator Trial [HAT]).
Allocation:
{concealed}.*
Blinding:
blinded (outcome adjudication committee).
Follow-up period:
median 37 months.
Setting:
178 clinical sites in the USA, Canada, Australia, the UK, New Zealand, the Netherlands, and Germany.
Patients:
7001 patients (median age 62 y, 83% men) who had had anterior-wall myocardial infarction, were not candidates for implantable cardioverter-defibrillator (ICD) therapy, and had a spouse or companion at home who was willing and able to perform the study interventions.
Intervention:
provision of an AED for home use (n = 3495) …
Footnotes
Source of funding: National Heart, Lung, and Blood Institute; Philips Medical Systems; Laerdal Medical.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.